SUN:ASXSuncorp Group Limited Analysis
Data as of 2026-07-17 - not real-time
A$19.05
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Suncorp’s price is trading above its short‑term moving averages, with the 20‑day line comfortably above the 50‑day line, reinforcing a bullish bias. The relative strength index sits in the upper‑mid range, indicating momentum remains positive but not yet overbought. However, the MACD histogram has turned negative and the signal line is higher than the MACD line, suggesting emerging bearish pressure. Trading volume has been on a downtrend, which could limit short‑term price thrusts. The broader market sentiment is in an “extreme greed” mode, which may further buoy the stock.
Fundamentally, the forward earnings multiple is substantially lower than the current trailing multiple and aligns more closely with the sector, hinting at earnings improvement ahead. The company’s price‑to‑earnings sits above the industry average, pointing to a modest premium that is not fully justified by growth rates. Dividend yield is modest, but the payout ratio exceeds sustainable levels, raising concerns about dividend continuity. A recent update highlighted higher natural‑hazard costs and a new reinsurance program, which could pressure margins in the near term. The discounted cash‑flow model suggests only a thin upside over the current price, while the market cap reflects a relatively low beta and limited volatility. Taken together, the stock appears fairly priced with a blend of growth and value characteristics, and the dividend may be at risk if earnings do not accelerate.
Fundamentally, the forward earnings multiple is substantially lower than the current trailing multiple and aligns more closely with the sector, hinting at earnings improvement ahead. The company’s price‑to‑earnings sits above the industry average, pointing to a modest premium that is not fully justified by growth rates. Dividend yield is modest, but the payout ratio exceeds sustainable levels, raising concerns about dividend continuity. A recent update highlighted higher natural‑hazard costs and a new reinsurance program, which could pressure margins in the near term. The discounted cash‑flow model suggests only a thin upside over the current price, while the market cap reflects a relatively low beta and limited volatility. Taken together, the stock appears fairly priced with a blend of growth and value characteristics, and the dividend may be at risk if earnings do not accelerate.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price above short‑term moving averages
- MACD bearish divergence
- declining volume
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- forward earnings multiple narrowing gap
- moderate premium to peers
- exposure to natural‑hazard cost volatility
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF indicates modest upside
- potential earnings improvement from reinsurance program
- low beta and defensive sector positioning
Key Metrics & Analysis
Financial Health
Revenue Growth1.70%
Profit Margin6.54%
P/E Ratio23.0
ROE8.40%
ROA2.83%
Debt/Equity22.54
P/B Ratio2.0
Op. Cash FlowA$1.7B
Free Cash FlowA$2.3B
Industry P/E18.0
Technical Analysis
TrendBullish
RSI58.7
SupportA$17.90
ResistanceA$19.44
MA 20A$18.95
MA 50A$18.16
MA 200A$17.53
MACDBearish
VolumeDecreasing
Fear & Greed Index88.73
Valuation
Fair ValueA$29.77
Target PriceA$19.28
Upside/Downside1.20%
GradeFair
TypeBlend
Dividend Yield1.79%
Risk Assessment
Beta0.18
Volatility20.00%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.